Phil Falkowitz's Clinical Trial Experience Is Featured in Journal Article
PMMNG member Phil Falkowitz started taking Revlimid (lenalidomide) way back in 2001, during the Phase 1 clinical trial of Revlimid. That trial went well for him (and for Revlimid).
What: Audio (59:29) and transcript from webinar